CME Group Inc.
CME
$285.75
$3.171.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.32B | 6.08B | 5.96B | 6.01B | 5.85B |
| Total Other Revenue | 424.50M | 422.60M | 423.00M | 425.60M | 428.20M |
| Total Revenue | 6.74B | 6.51B | 6.39B | 6.43B | 6.27B |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 6.74B | 6.51B | 6.39B | 6.43B | 6.27B |
| SG&A Expenses | 1.79B | 1.75B | 1.69B | 1.68B | 1.65B |
| Depreciation & Amortization | 331.70M | 330.90M | 331.90M | 333.20M | 334.00M |
| Other Operating Expenses | 161.10M | 166.10M | 196.50M | 204.30M | 201.20M |
| Total Operating Expenses | 2.28B | 2.25B | 2.22B | 2.22B | 2.19B |
| Operating Income | 4.46B | 4.26B | 4.16B | 4.21B | 4.09B |
| Income Before Tax | 5.60B | 5.33B | 4.85B | 4.85B | 4.67B |
| Income Tax Expenses | 1.33B | 1.26B | 1.08B | 1.08B | 1.05B |
| Earnings from Continuing Operations | 4.27K | 4.07K | 3.76K | 3.77K | 3.63K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.27B | 4.07B | 3.76B | 3.77B | 3.63B |
| EBIT | 4.46B | 4.26B | 4.16B | 4.21B | 4.09B |
| EBITDA | 4.79B | 4.59B | 4.49B | 4.55B | 4.42B |
| EPS Basic | 11.81 | 11.18 | 10.33 | 10.35 | 9.96 |
| Normalized Basic EPS | 9.70 | 9.23 | 8.41 | 8.41 | 8.11 |
| EPS Diluted | 11.72 | 11.16 | 10.32 | 10.33 | 9.94 |
| Normalized Diluted EPS | 9.66 | 9.22 | 8.40 | 8.40 | 8.10 |
| Average Basic Shares Outstanding | 1.44B | 1.44B | 1.44B | 1.44B | 1.44B |
| Average Diluted Shares Outstanding | 1.44B | 1.44B | 1.44B | 1.44B | 1.44B |
| Dividend Per Share | 5.05 | 5.00 | 4.90 | 4.80 | 4.70 |
| Payout Ratio | 95.15% | 96.58% | 103.53% | 102.42% | 105.42% |